BiotechTube
Home/Pipeline/Drug Discovery & Development Partnerships

Drug Discovery & Development Partnerships

Various

Discovery/Pre-clinicalActive

Key Facts

Indication
Various
Phase
Discovery/Pre-clinical
Status
Active
Company
IMU Biosciences

About IMU Biosciences

IMU Biosciences is an early-stage biotech leveraging AI and multi-omics to map the immune system at unprecedented scale and resolution. Its proprietary platform, built on research from King's College London and the Francis Crick Institute, analyzes vast immune datasets to discover novel signatures for drug development and precision medicine applications. The company is positioned as a platform and discovery partner for pharmaceutical companies, aiming to increase R&D success and enable immune-driven diagnostics and therapies.

View full company profile

Therapeutic Areas

Immune-related diseases

Other Various Drugs

DrugCompanyPhase
New Generic ApprovalsChina SXT PharmaceuticalsApplication Submitted / BE Stage
New Dosage Form DevelopmentUniverse PharmaceuticalsDevelopment
New TCM Formula RegistrationUniverse PharmaceuticalsDevelopment
CBD/THC Oil FormulationAvecho BiotechnologyPreclinical
Bag APIsChemWerthApproved
Oral APIsChemWerthApproved
Companion Diagnostics DevelopmentKiffik BiomedicalPre-clinical
Portfolio of Complex Generics & 505(b)(2) ProductsAlvogenApproved/Commercial
Portfolio of 40+ productsPraxgen PharmaceuticalsDevelopment
Drug Repositioning ServiceBiovistaService
Custom Control DevelopmentAnchor MolecularDevelopment/Commercial
Portfolio from Steriscience PartnershipArmas PharmaceuticalsANDA Development/Filing